Toms, Andoni P.
Rifai, Tamam
Whitehouse, Celia
McNamara, Iain
Funding for this research was provided by:
gwen fish orthopaedic research trust
smith and nephew orthopaedics
Article History
Received: 2 July 2021
Revised: 31 October 2021
Accepted: 25 November 2021
First Online: 10 February 2022
Declarations
:
: The scientific guarantor of this publication is Andoni P. Toms
: Iain McNamara has been paid to carry out research by Smith & Nephew and has advised on research protocols. The other authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: One of the authors has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: The methodology <i>only</i> for the CAPAbility clinical trial has been reported in:Clarke C, Pomeroy V, Clark A, Creelman G, Hancock N, Horton S, Killett A, Mann C, Payerne E, Toms A, Roberts G, Smith T, Swart AM, McNamara I. CAPAbility: comparison of the JOURNEY II Bi-Cruciate Stabilised and GENESIS II total knee arthroplasty in performance and functional ability: protocol of a randomised controlled trial. Trials. 2020 Feb 24;21(1):222.No study subjects or cohorts have been previously reported.
: • prospective• cross-sectional study• performed at one institution